Here he goes again...

Not satisfied with his frequent dragging up a four year old recommendation that finally (and for the first time) looks good enough to chase, he is into outright gambling under the guise of investing.

He makes his own case by indicating AbbVie is a one-trick pony with most of its revenue derived from a patent-expiring drug, then pulls out the crystal ball and speculates how hard it might be for competitors to practically copy its benefits, and enters the truly bizarre forecasting world by saying they have lots of goodies in the pipeline. He's a medical researcher too, knowing the value and certainty of drugs not yet on the market?

Casino odds at craps look pretty good when contrasted with this wild gamble!